Rocklatan approval tops recent glaucoma news

The FDA’s approval of Rocklatan and news updates from the American Glaucoma Society meeting were among the most-read glaucoma-related articles on in recent weeks.
Here are the top five recent glaucoma stories:
FDA approves Rocklatan for open-angle glaucoma, ocular hypertension
A fixed-dose combination of netarsudil and latanoprost, Rocklatan — previously known as Roclatan — is designed to target the trabecular meshwork, which is considered the main cause of elevated IOP. Read more.
Kahook Dual Blade reduces IOP with and without phaco
The Kahook Dual

Full Story →